Prasansuklab, A., Sukjamnong, S., Theerasri, A., Hu, V. W., Sarachana, T., & Tencomnao, T. (2023). Transcriptomic analysis of glutamate-induced HT22 neurotoxicity as a model for screening anti-Alzheimer’s drugs. Nature Portfolio.
Chicago-referens (17:e uppl.)Prasansuklab, Anchalee, Suporn Sukjamnong, Atsadang Theerasri, Valerie W. Hu, Tewarit Sarachana, och Tewin Tencomnao. Transcriptomic Analysis of Glutamate-induced HT22 Neurotoxicity as a Model for Screening Anti-Alzheimer’s Drugs. Nature Portfolio, 2023.
MLA-referens (9:e uppl.)Prasansuklab, Anchalee, et al. Transcriptomic Analysis of Glutamate-induced HT22 Neurotoxicity as a Model for Screening Anti-Alzheimer’s Drugs. Nature Portfolio, 2023.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.